Literature DB >> 19828320

Synthesis and in vitro evaluation of aspartate transcarbamoylase inhibitors.

Laëtitia Coudray1, Anne F Pennebaker, Jean-Luc Montchamp.   

Abstract

The design, synthesis, and evaluation of a series of novel inhibitors of aspartate transcarbamoylase (ATCase) are reported. Several submicromolar phosphorus-containing inhibitors are described, but all-carboxylate compounds are inactive. Compounds were synthesized to probe the postulated cyclic transition-state of the enzyme-catalyzed reaction. In addition, the associated role of the protonation state at the phosphorus acid moiety was evaluated using phosphinic and carboxylic acids. Although none of the synthesized inhibitors is more potent than N-phosphonacetyl-l-aspartate (PALA), the compounds provide useful mechanistic information, as well as the basis for the design of future inhibitors and/or prodrugs.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19828320      PMCID: PMC2783949          DOI: 10.1016/j.bmc.2009.09.045

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  51 in total

1.  Design, synthesis and activity of bisubstrate, transition-state analogues and competitive inhibitors of aspartate transcarbamylase.

Authors:  Claude Grison; Philippe Coutrot; Corinne Comoy; Laurence Balas; Stéphane Joliez; Guido Lavecchia; Patrick Oliger; Bernadette Penverne; Valérie Serre; Guy Hervé
Journal:  Eur J Med Chem       Date:  2004-04       Impact factor: 6.514

2.  Inhibitor Ionization as a Determinant of Binding to 3-Dehydroquinate Synthase.

Authors:  Feng Tian; Jean-Luc Montchamp; J. W. Frost
Journal:  J Org Chem       Date:  1996-10-18       Impact factor: 4.354

3.  Binding of radiolabeled N-(phosphonacetyl)-L-aspartate to aspartate transcarbamylase from Ehrlich ascites tumor cells.

Authors:  J C White; L H Hines
Journal:  Biochem Pharmacol       Date:  1984-11-15       Impact factor: 5.858

Review 4.  How to get the most out of two phosphorus chemistries. Studies on H-phosphonates.

Authors:  Jacek Stawinski; Adam Kraszewski
Journal:  Acc Chem Res       Date:  2002-11       Impact factor: 22.384

5.  Dehydroquinate synthase: the use of substrate analogues to probe the late steps of the catalyzed reaction.

Authors:  T Widlanski; S L Bender; J R Knowles
Journal:  Biochemistry       Date:  1989-09-19       Impact factor: 3.162

6.  N-phosphonacetyl-L-isoasparagine a potent and specific inhibitor of Escherichia coli aspartate transcarbamoylase.

Authors:  Joby Eldo; James P Cardia; Elizabeth M O'Day; Jiarong Xia; Hiro Tsuruta; Evan R Kantrowitz
Journal:  J Med Chem       Date:  2006-10-05       Impact factor: 7.446

7.  Palladium-catalyzed hydrophosphinylation of alkenes and alkynes.

Authors:  Sylvine Deprèle; Jean-Luc Montchamp
Journal:  J Am Chem Soc       Date:  2002-08-14       Impact factor: 15.419

8.  Synthesis and biological activity of a series of aspartate transcarbamoylase inhibitors: N-substituted diethyl aspartates and N-substituted-3-oxo-1,4-piperazine-2-acetic acid esters.

Authors:  P L Dutta; W O Foye
Journal:  J Pharm Sci       Date:  1990-05       Impact factor: 3.534

9.  L-(+)-2-Amino-4-thiophosphonobutyric acid (L-thioAP4), a new potent agonist of group III metabotropic glutamate receptors: increased distal acidity affords enhanced potency.

Authors:  Chelliah Selvam; Cyril Goudet; Nadia Oueslati; Jean-Philippe Pin; Francine C Acher
Journal:  J Med Chem       Date:  2007-08-28       Impact factor: 7.446

10.  1,1-Bisphosphonate squalene synthase inhibitors: interplay between the isoprenoid subunit and the diphosphate surrogate.

Authors:  D R Magnin; S A Biller; J K Dickson; J V Logan; R M Lawrence; Y Chen; R B Sulsky; C P Ciosek; T W Harrity; K G Jolibois
Journal:  J Med Chem       Date:  1995-07-07       Impact factor: 7.446

View more
  1 in total

Review 1.  Phosphinate-containing heterocycles: A mini-review.

Authors:  Olivier Berger; Jean-Luc Montchamp
Journal:  Beilstein J Org Chem       Date:  2014-03-27       Impact factor: 2.883

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.